Bimatoprost diethyl amide
QUICK LINKS
Bimatoprost diethyl amide is an analog of PGF2α wherein the C-1 carboxyl group has been modified to an N-diethyl amide. Prostaglandin esters have been shown to have ocular hypotensive activity.1 Prostaglandin N-ethyl amides were recently introduced as alternative prostaglandin hypotensive prodrugs.2 Studies have shown that bovine and human corneal tissue converts the N-ethyl amides of various prostaglandins to the free acids with a conversion efficiency of about 2.5 µg/g corneal tissue/hr.3 However, dialkyl amides such as bimatoprost diethyl amide are inert to corneal amidase activity, and are not converted in any detectable amount to the corresponding free acids. These compounds may therefore be useful tools in elucidating the claim that prostaglandin amides have intrinsic intraocular hypotensive activity.
Bimatoprost diethyl amide References
- The pharmacology of bimatoprost (Lumigan). | Woodward, DF., et al. 2001. Surv Ophthalmol. 45 Suppl 4: S337-45. PMID: 11434936
- The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist. | Maxey, KM., et al. 2002. Surv Ophthalmol. 47 Suppl 1: S34-40. PMID: 12204699
- Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. | Bito, LZ. 1984. Exp Eye Res. 38: 181-94. PMID: 6370708
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Bimatoprost diethyl amide, 1 mg | sc-221359 | 1 mg | $60.00 | |||
Bimatoprost diethyl amide, 5 mg | sc-221359A | 5 mg | $272.00 |